Cerus (CERS) Income from Non-Controlling Interests (2022 - 2026)
Cerus (CERS) posted Income from Non-Controlling Interests of -$42000.0 for Q2 2026, down 425.0% sequentially from -$8000.0 in Q1 2026, and down 425.0% YoY from $12923.1 in Q2 2025.
Cerus (CERS) Income from Non-Controlling Interests (2022 - 2026) Analysis & Trends
Cerus has reported Income from Non-Controlling Interests for 5 years, with the latest figure at -$42000.0 in Q2 2026.
- Quarterly Income from Non-Controlling Interests fell 425.0% year-over-year to -$42000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$51000.0 (down 2.0% YoY) and the FY2025 annual result came in at -$10000.0, up 76.74% from the prior year.
- Income from Non-Controlling Interests eased to -$42000.0 in Q2 2026 per CERS's latest filing, from -$8000.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at -$1000.0 in Q4 2022 and troughed at -$61000.0 in Q4 2023.
- A 5-year average of -$21928.6 and a median of -$13500.0 in 2023 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2023 and 2024: Income from Non-Controlling Interests tumbled 6000.0% in 2023, then soared 90.91% in 2024.
- Over 5 years, Income from Non-Controlling Interests stood at -$1000.0 in 2022, then sank by 6000.0% to -$61000.0 in 2023, then soared by 32.79% to -$41000.0 in 2024, then jumped by 97.56% to -$1000.0 in 2025, then tumbled by 4100.0% to -$42000.0 in 2026.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered -$42000.0, -$8000.0, and -$1000.0 for Q2 2026, Q1 2026, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 900,000.00 |
| 10 | Cerus | 560.58 Mn | 504.32 Mn | 29.53 Mn | -42,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -42,000.00 |
| Mar 31, 2026 | -8,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -8,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -41,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | -61,000.00 |
| Sep 30, 2023 | -19,000.00 |
| Jun 30, 2023 | -56,000.00 |
| Mar 31, 2023 | -22,000.00 |
| Dec 31, 2022 | -1,000.00 |
| Sep 30, 2022 | -39,000.00 |
| Jun 30, 2022 | -6,000.00 |